Targeting GPR173 for Drug-Resistant Epilepsy Treatment | Promising Gene Therapy Reduces Seizures in Mouse Models

In this episode of SciBud, we explore groundbreaking research that could transform the treatment landscape for drug-resistant epilepsy, affecting 30-40% of patients who find little relief from current medications. Join Rowan as we delve into the fascinating role of the protein GPR173 and its potential as a novel gene therapy approach. Through cutting-edge experiments in mouse models, researchers have discovered that increasing GPR173 levels in excitatory neurons can significantly reduce spontaneous seizures by restoring balance in brain activity. While promising, the study also highlights important considerations about methodology transparency and the need for further investigation into long-term effects. Tune in to find out how this innovative strategy might pave the way for new therapies, offering hope to those struggling with this challenging neurological disorder. Stay curious with us as we unravel the wonders of science and its real-world implications! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/236